|
C11ORF95 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63058455626697E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
3.54610000000699E-05 |
| Normal-vs-Stage3 |
5.32269994746315E-09 |
| Normal-vs-Stage4 |
1.02660000500521E-08 |
| Stage1-vs-Stage2 |
3.521600E-01 |
| Stage1-vs-Stage3 |
7.562200E-01 |
| Stage1-vs-Stage4 |
8.799400E-01 |
| Stage2-vs-Stage3 |
6.449200E-01 |
| Stage2-vs-Stage4 |
5.320600E-01 |
| Stage3-vs-Stage4 |
7.666600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-15 |
| Normal-vs-AfricanAmerican |
5.54445378497803E-13 |
| Normal-vs-Asian |
2.47029999789206E-08 |
| Caucasian-vs-AfricanAmerican |
6.786600E-01 |
| Caucasian-vs-Asian |
1.774770E-01 |
| AfricanAmerican-vs-Asian |
1.469650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
3.59234864077962E-12 |
| Male-vs-Female |
2.585800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.94799998354256E-09 |
| Normal-vs-Extreme_Weight |
1.62592161956354E-12 |
| Normal-vs-Obese |
3.27937677013779E-12 |
| Normal-vs-Extreme_Obese |
1.85320003787126E-09 |
| Normal_Weight-vs-Extreme_Weight |
1.540160E-01 |
| Normal_Weight-vs-Obese |
6.994800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.193800E-01 |
| Extreme_Weight-vs-Obese |
2.206400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.308000E-01 |
| Obese-vs-Extreme_Obese |
2.877600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.20529999997543E-06 |
| Normal-vs-Age(41-60Yrs) |
1.72706293710689E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
7.19080350819468E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.005200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.885600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.396000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.664500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.660100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.452400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.15063555642337E-14 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
2.392200E-02 |
| Normal-VS-Unclassified PRCC |
2.17126316925942E-12 |
| Type1 PRCC-VS-Type2 PRCC |
2.437500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.635100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.495600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.55545999999118E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
4.096200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.583600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.12029996390817E-09 |
| Normal-vs-N2 |
4.965000E-04 |
| N0-vs-N1 |
8.273800E-02 |
| N0-vs-N2 |
3.605800E-01 |
| N1-vs-N2 |
9.654400E-01 |
|
|
